Director Myra J. Biblowit filed a Form 4 with the SEC on October 27, 2026, reporting two acquisitions of Wyndham Hotels & Resorts, Inc. common stock and deferred stock units on October 23, 2026.

Key Highlights

  • Retainer shares acquired: Biblowit received 544 shares of common stock issued for quarterly retainer fees at a price of $72.42 per share on October 23, 2026.
  • Deferred stock units acquired: 554 deferred stock units were issued for quarterly dividends at $72.42, bringing her total deferred stock units to 93,835.
  • Direct common stock holdings: Following the retainer share acquisition, Biblowit directly held 16,152 shares of common stock.
  • Restricted stock units: The filing separately discloses 3,742 restricted stock units held directly.
  • Deferred stock unit terms: According to the filing, each deferred stock unit entitles the reporting person to receive one share of common stock following retirement or termination of service from the Board of Directors.
  • Reporting relationship: Biblowit is identified as a Director of Wyndham Hotels & Resorts, Inc. (NYSE:WH).

Biblowit's October 2026 Quarterly Retainer and Dividend Unit Awards at Wyndham Hotels

According to the Form 4 filed October 27, 2026, Director Myra J. Biblowit of Wyndham Hotels & Resorts, Inc. (NYSE:WH) reported two acquisition transactions, both dated October 23, 2026. The first was 544 shares of common stock issued as quarterly retainer fees at a price of $72.42 per share. Following this transaction, the filing reports her direct beneficial ownership of common stock at 16,152 shares.

The second transaction reported was the acquisition of 554 deferred stock units, described in the filing as "issued for quarterly dividends." These were also recorded at a price of $72.42. The filing notes that "each deferred stock unit entitles the reporting person to receive one share of common stock following the reporting person's retirement or termination of service from the Board of Directors." After this transaction, Biblowit's total directly held deferred stock units stood at 93,835, according to the filing.

Additionally, the filing discloses 3,742 restricted stock units held directly by Biblowit, reported without an associated transaction date in Table I. No derivative securities transactions were reported in Table II. The Form 4 was signed by Paul F. Cash as Attorney-in-Fact for Myra J. Biblowit and filed on October 27, 2026. No Rule 10b5-1 plan box was checked for these transactions.

What Was Disclosed

The filing disclosed two October 23, 2026 acquisitions by Director Myra J. Biblowit: 544 common shares for quarterly retainer fees and 554 deferred stock units for quarterly dividends, both at $72.42, plus an existing holding of 3,742 restricted stock units.